David Eidelberg

31.0k total citations · 4 hit papers
365 papers, 22.3k citations indexed

About

David Eidelberg is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, David Eidelberg has authored 365 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Neurology, 126 papers in Cellular and Molecular Neuroscience and 99 papers in Cognitive Neuroscience. Recurrent topics in David Eidelberg's work include Neurological disorders and treatments (225 papers), Parkinson's Disease Mechanisms and Treatments (187 papers) and Genetic Neurodegenerative Diseases (86 papers). David Eidelberg is often cited by papers focused on Neurological disorders and treatments (225 papers), Parkinson's Disease Mechanisms and Treatments (187 papers) and Genetic Neurodegenerative Diseases (86 papers). David Eidelberg collaborates with scholars based in United States, Germany and Canada. David Eidelberg's co-authors include Vijay Dhawan, Yilong Ma, Andrew Feigin, Maren Carbon, Phoebe G. Spetsieris, Chengke Tang, James R. Moeller, Stanley Fahn, Paul J. Mattis and Thomas Chaly and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David Eidelberg

358 papers receiving 21.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease

2001 1.7k citations David Eidelberg, Stanley Fahn et al. profile →
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

2007 775 citations Andrew Feigin, Chengke Tang et al. profile →
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

2022 186 citations Yilong Ma, Shichun Peng et al. profile →
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

2025 25 citations Viviane Tabar, Harini Sarva et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Eidelberg United States	84	13.9k	8.3k	5.6k	3.4k	2.9k	365	22.3k
Klaus L. Leenders Netherlands	71	8.2k 0.6×	6.2k 0.7×	3.0k 0.5×	3.0k 0.9×	2.5k 0.9×	300	17.3k
Marie Vidailhet France	68	13.3k 1.0×	6.0k 0.7×	3.2k 0.6×	1.3k 0.4×	1.4k 0.5×	342	17.8k
Thomas Foltynie United Kingdom	75	15.4k 1.1×	7.4k 0.9×	4.6k 0.8×	1.0k 0.3×	2.3k 0.8×	284	20.6k
Roger L. Albin United States	75	10.6k 0.8×	11.6k 1.4×	3.6k 0.6×	942 0.3×	6.3k 2.2×	315	21.8k
Jens Volkmann Germany	69	15.1k 1.1×	8.1k 1.0×	4.6k 0.8×	942 0.3×	1.6k 0.6×	373	21.4k
Niall Quinn United Kingdom	93	24.9k 1.8×	12.0k 1.4×	3.1k 0.6×	1.1k 0.3×	4.5k 1.5×	326	31.7k
Jun Kimura Japan	68	6.2k 0.4×	5.5k 0.7×	2.4k 0.4×	1.8k 0.5×	4.7k 1.6×	401	18.5k
Roger A. Barker United Kingdom	95	18.2k 1.3×	12.4k 1.5×	7.5k 1.3×	1.5k 0.4×	9.3k 3.2×	568	34.6k
Jan Kassubek Germany	60	7.6k 0.5×	3.0k 0.4×	2.7k 0.5×	2.3k 0.7×	1.7k 0.6×	437	13.6k
Charles H. Adler United States	73	19.5k 1.4×	5.3k 0.6×	4.3k 0.8×	1.1k 0.3×	2.7k 0.9×	313	25.7k

Countries citing papers authored by David Eidelberg

Since Specialization

Citations

This map shows the geographic impact of David Eidelberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eidelberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eidelberg more than expected).

Fields of papers citing papers by David Eidelberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Eidelberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eidelberg. The network helps show where David Eidelberg may publish in the future.

Co-authorship network of co-authors of David Eidelberg

This figure shows the co-authorship network connecting the top 25 collaborators of David Eidelberg. A scholar is included among the top collaborators of David Eidelberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Eidelberg. David Eidelberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tabar, Viviane, Harini Sarva, Andrés M. Lozano, et al.. (2025). Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease. Nature. 641(8064). 978–983. 25 indexed citations breakdown →

Dhawan, Vijay, Shichun Peng, Phoebe G. Spetsieris, David Eidelberg, & Yilong Ma. (2025). Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach. Movement Disorders. 40(8). 1511–1527.

Tang, Chris C., Yoshikazu Nakano, An Vo, et al.. (2024). Longitudinal network changes and phenoconversion risk in isolated REM sleep behavior disorder. Nature Communications. 15(1). 10797–10797. 4 indexed citations

Niethammer, Martin, Chris C. Tang, Roland Dominic G. Jamora, et al.. (2023). A Network Imaging Biomarker of X‐Linked Dystonia‐Parkinsonism. Annals of Neurology. 94(4). 684–695. 3 indexed citations

Barbero, J., et al.. (2023). Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease. Neurotherapeutics. 20(6). 1653–1668. 2 indexed citations

Vo, An, Nha Nguyen, Koji Fujita, et al.. (2023). Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses. Cerebral Cortex. 33(11). 6943–6958. 6 indexed citations

Schindlbeck, Katharina A., et al.. (2022). Functional brain networks in the evaluation of patients with neurodegenerative disorders. Nature Reviews Neurology. 19(2). 73–90. 51 indexed citations

Vo, An, Katharina A. Schindlbeck, Nha Nguyen, et al.. (2022). Adaptive and pathological connectivity responses in Parkinson’s disease brain networks. Cerebral Cortex. 33(4). 917–932. 13 indexed citations

Schindlbeck, Katharina A., Chris C. Tang, An Vo, et al.. (2022). Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease. Movement Disorders. 37(11). 2247–2256. 9 indexed citations

10.

Schindlbeck, Katharina A., Deepak Gupta, Chris C. Tang, et al.. (2021). Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3522–3529. 13 indexed citations

11.

Vo, An, et al.. (2021). Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study. SHILAP Revista de lepidopterología. 1(3). 100026–100026. 11 indexed citations

12.

Mackay, Meggan, An Vo, Chris C. Tang, et al.. (2019). Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment. JCI Insight. 4(1). 55 indexed citations

13.

Ge, Jingjie, Jian Wu, Shichun Peng, et al.. (2018). Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts. Human Brain Mapping. 39(7). 2842–2858. 33 indexed citations

14.

Schindlbeck, Katharina A., Chris C. Tang, Martin Niethammer, et al.. (2017). Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia. JCI Insight. 2(20). 16 indexed citations

15.

Fujita, Koji, Wataru Sako, An Vo, Susan Bressman, & David Eidelberg. (2017). Disruption of network for visual perception of natural motion in primary dystonia. Human Brain Mapping. 39(3). 1163–1174. 4 indexed citations

16.

Holtbernd, Florian, Jean‐François Gagnon, Ron B. Postuma, et al.. (2014). Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 82(7). 620–627. 137 indexed citations

17.

Huang, Chaorui, Paul J. Mattis, Kenneth Perrine, et al.. (2008). Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology. 70(16_part_2). 1470–1477. 191 indexed citations

18.

Hirano, Shigeki, Kotaro Asanuma, Yilong Ma, et al.. (2008). Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease. Journal of Neuroscience. 28(16). 4201–4209. 117 indexed citations

19.

Nakamura, Tomoya, M. F. Ghilardi, Marc J. Mentis, et al.. (2000). Functional networks in motor sequence learning: Abnormal topographies in Parkinson's disease. Human Brain Mapping. 12(1). 42–60. 112 indexed citations

20.

Eidelberg, David. (1998). Functional brain networks in movement disorders. Current Opinion in Neurology. 11(4). 319–326. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact